Company Developments - Afya Limited (AFYA) has received authorization to increase medical seats at Centro Universitário de Maceió (UNIMA Alagoas) to a total of 220, adding 80 new seats, which will require an additional payment of R$ 1.25 million per seat approved [1] - The increase in medical seats contributes to AFYA's total of 3,583 approved seats, enhancing its capacity to provide quality medical education in Brazil [1] Price Performance - AFYA's shares have increased by 5.6% over the past three months, outperforming the Zacks Schools industry's growth of 3.1% [2] - The Zacks Consensus Estimate for AFYA's 2024 earnings per share (EPS) has been revised upward to $1.63, reflecting a year-over-year growth of 27.3% [2] - The estimate for second-quarter EPS has also increased, indicating a growth of 27.6% compared to the same quarter last year [2] Analyst Ratings - AFYA holds a Zacks Rank of 2 (Buy), indicating positive analyst sentiment towards the stock [4] - The company has a VGM Score of A, supported by both Value and Growth Scores of A, reflecting strong analyst optimism about its potential [3]

Core Viewpoint - The article emphasizes the importance of value investing and highlights specific companies, Afya (AFYA) and Adtalem Global Education (ATGE), as strong value stocks based on their financial metrics and Zacks Rank. Company Analysis: Afya (AFYA) - Afya holds a Zacks Rank of 2 (Buy) and a Value grade of A, indicating strong potential for value investors [2] - The current P/E ratio for AFYA is 9.79, significantly lower than the industry average of 20.49 [2] - AFYA's Forward P/E has fluctuated between 8.83 and 18.02 over the past year, with a median of 10.98 [2] - The PEG ratio for AFYA is 0.41, compared to the industry average of 1.21, indicating strong growth potential relative to its valuation [2] - Over the last 12 months, AFYA's PEG has ranged from 0.39 to 1.02, with a median of 0.57 [2] - The P/B ratio for AFYA is 2.13, which is lower than the industry average of 3.45, suggesting it may be undervalued [3] - AFYA's P/B has varied between 1.90 and 2.87 over the past year, with a median of 2.16 [3] Company Analysis: Adtalem Global Education (ATGE) - Adtalem Global Education also holds a Zacks Rank of 2 (Buy) and a Value score of A, making it another attractive option for value investors [4] - The Forward P/E ratio for ATGE is 11.70, which is lower than the industry average of 20.49 [4] - ATGE's PEG ratio is 0.78, again lower than the industry average of 1.21, indicating potential undervaluation [4] - Over the past year, ATGE's Forward P/E has ranged from 8.25 to 13.86, with a median of 10.25 [4] - The P/B ratio for ATGE is 1.91, compared to the industry average of 3.45, further supporting its value proposition [4] - ATGE's P/B has fluctuated between 1.06 and 1.94 over the past year, with a median of 1.43 [4] Conclusion - Both Afya and Adtalem Global Education exhibit strong value characteristics based on their financial metrics, suggesting they are currently undervalued in the market [4]

Afya Limited (AFYA) completed the acquisition of the total share capital of Unidom Participacoes S.A. (Unidompedro and Faculdade Dom Luiz) through its wholly-owned subsidiary Afya Participacoes S.A.This strategic buyout will provide Afya with 300 operational medical school seats in Brazil’s Salvador city. The average purchase price of this strategic transaction was R$ 660.0 million, of which R$ 347.8 million is already paid (net debt deduction) and the remaining R$ 312.2 million will be paid in about 10 ann ...

Afya (AFYA) closed the last trading session at $17.32, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $23 indicates a 32.8% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $2.83. While the lowest estimate of $19 indicates a 9.7% increase from the current price level, the most optimistic analyst expects the stock ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value ...

Investors interested in stocks from the Schools sector have probably already heard of Afya (AFYA) and Bright Horizons Family Solutions (BFAM) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and ...

Afya Limited (NASDAQ:AFYA) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Renata Couto - IR Virgilio Gibbon - CEO Luis Andre Blanco - CFO Conference Call Participants Lucca Marquezini - Itau Mirela Oliveira – Bank of America Marcelo Santos - JPMorgan Lucas Nagano - Morgan Stanley Leandro Bastos - Citi Renata Couto Good night, everyone. Thank you for joining us for Afya's First Quarter 2024 Conference Call. I'm here today with Afya's CEO, Virgilio Gibbon; and Luis Andre Blanco, ...

Afya (AFYA) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 17.02%. A quarter ago, it was expected that this medical education company would post earnings of $0.34 per share when it actually produced earnings of $0.36, delivering a surprise of 5.88%.Over the last four quarters, the co ...

Afya Limited Unaudited interim condensed consolidated financial statements March 31, 2024 Afya Limited Unaudited interim condensed consolidated statements of financial position As of March 31, 2024 and December 31, 2023 | | Notes | March 31, 2024 | December 31, 2023 | | --- | --- | --- | --- | | | | (unaudited) | | | Assets | | | | | Current assets | | | | | Cash and cash equivalents | 4 | 611,077 | 553,030 | | Trade receivables | 5 | 536,175 | 546,438 | | Inventories | | 653 | 1,382 | | Recoverable taxes | ...

Investors looking for stocks in the Schools sector might want to consider either Afya (AFYA) or Grand Canyon Education (LOPE) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, whi ...